"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Penicilline","Ampicillina",5891,"89.3","88.5","90.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Aminoglicosidi (alto dosaggio)","Gentamicina",2597,"58.0","56.1","59.9"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Aminoglicosidi (alto dosaggio)","Streptomicina",3401,"62.7","61.1","64.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Glicopeptidi","Vancomicina",5910,"30.7","29.5","31.9"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Glicopeptidi","Teicoplanina",5846,"30.5","29.4","31.7"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2022.pdf","Ossazolidinoni","Linezolid",5769,"1.6","1.3","1.9"
